Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
Vericel Rises 12%; Prel. Annual Revenue In Line With Estimates
-
Crypto Winter Forces LocalBitcoins To Shut Down Operations
-
Banks To Innovate With Caution On Crypto-Asset-Related Activities – Fed Official
-
Cryptos Subdued But Bitcoin Firm Above $30k
-
Barbie Star's Bitcoin Remarks Ignite Discussions in Crypto World